David Reed is a trial and appellate attorney who has represented prominent innovators and technology-focused companies for almost 20 years. As an intellectual property litigator and strategist, Mr. Reed regularly counsels clients in their most complex and consequential patent disputes.
Combining deep technical expertise with his experience in courtrooms around the country, Mr. Reed has earned a reputation for achieving favorable results. He has represented clients in over 100 patent infringement cases spanning a diverse range of technologies including electronics, telecommunications, mechanical devices, materials science, and consumer products. Mr. Reed’s background in chemistry affords him particular technical expertise in the life sciences, and he has litigated numerous Hatch-Waxman cases and post-grant proceedings involving small molecule drugs and pharmaceutical formulations.
Mr. Reed has tried cases to verdict in Delaware, Florida, Georgia, Pennsylvania, Texas, and the International Trade Commission. He is also a registered patent attorney and top practitioner before the Patent Trial and Appeal Board, representing clients in over 40 post-grant proceedings to date. Mr. Reed has an active appellate practice, regularly appearing before the Court of Appeals for the Federal Circuit.
Complementing his national litigation practice, Mr. Reed is active in the community. He has served in leadership roles in the intellectual property sections of the State Bar of Georgia and the Atlanta Bar Association. He co-founded and served on the board of directors of the Georgia Tech Bar Association and also was a founder of the Georgia Intellectual Property Alliance. He has been elected to membership of The Honorable Charles A. Pannell, Jr. Intellectual Property Inn of Court. Mr. Reed regularly speaks and writes on developments in patent law.
Mr. Reed has been recognized by The Best Lawyers in America® in the area of intellectual property litigation and was named as a “Rising Star” for intellectual property by Super Lawyers magazine. Mr. Reed is a member of Kilpatrick Townsend’s intellectual property department, which has been recognized by Chambers USA as “the leading IP practice in Georgia.” In recent years, Kilpatrick Townsend has been named “Firm of the Year” for IP litigation by U.S. News and as “Americas IP Firm of the Year” by Managing IP.
Mr. Reed received a B.S. in Chemical Engineering from the Georgia Institute of Technology where he received the Institute’s Henry Ford II Scholar award for achieving the highest academic standing among undergraduates. He received a J.D. from the University of Virgina School of Law, where he served as Editor of the Virginia Journal of Law and Technology. Before his legal career, Mr. Reed was a process engineer for a major chemical company.
In his spare time, Mr. Reed enjoys traveling and spending time with his wife and two young daughters. His travels have taken him to over 50 countries around the globe.
Experience
Defended adidas in a Section 337 investigation brought by Nike in the ITC related to the design and manufacture of shoe uppers for knitted footwear.
Defended Motorola Mobility in patent litigation related to wireless headphones in the Western District of Texas; won jury verdicts of non-infringement and invalidity.
Represented Manufacturing Resources International, the leading domestic outdoor LCD display manufacturer, in ITC unfair import investigations against Samsung related to thermal management systems for electronic displays.
Defended Google and Motorola in the District of Delaware and related IPR proceedings related to the scalable display of Internet content on mobile devices; won determinations of invalidity of the asserted patents and affirmance on appeal.
Defended Zodiac Aerospace and its subsidiaries in multi-front litigation relating to commercial aircraft enclosures and runway arresting systems; successfully defeated preliminary injunction motions in the Eastern District of Texas and won related IPR trials and appeals.
Represented a global pharmaceutical company in Hatch-Waxman litigation concerning a drug for treating an endocrine disorder.
Defended the manufacturer of the active pharmaceutical ingredient of a drug for treating osteoporosis in a Section 337 investigation before the ITC.
Represented a clinical stage ophthalmology company in PTAB proceedings relating to a drug for treating ocular disorders.
Insights View All
Events
University of Virginia School of Law J.D. (2006)
Georgia Institute of Technology B.S. (2002) Chemical Engineering
Georgia (2006)
Supreme Court of Georgia
Supreme Court of the United States
U.S. Court of Appeals for the Eleventh Circuit
U.S. Court of Appeals for the Federal Circuit
U.S. Court of Federal Claims
U.S. District Court for the Eastern District of Texas
U.S. District Court for the Eastern District of Wisconsin
U.S. District Court for the Middle District of Georgia
U.S. District Court for the Northern District of Georgia
U.S. Patent and Trademark Office
American Bar Association, Intellectual Property Law Section
American Intellectual Property Law Association
Atlanta Bar Association, Intellectual Property Section
Federal Bar Association
Federal Circuit Bar Association
Georgia Intellectual Property Alliance, Founder
Georgia Tech Bar Association, Co-founder
Intellectual Property Owners Association
International Trade Commission Trial Lawyers Association
State Bar of Georgia, Intellectual Property Law Section
Disclaimer
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.